Solid Biosciences Inc. (SLDB) stock
SLDBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.84−0.16 (-2.29%)
Close on Nov 13, 2026Market cap $733.42MP/E –Yield –
Solid Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Solid Biosciences's enterprise value was $421.25M on Nov 11, 2026, against $186.80M a year earlier. Over the last 5 years it ranged from -$145.99M to $629.40M, with a median of $832.12K.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $421.25M | +107.4% |
| 2025 | Dec 31, 2025 | $203.16M | – |
| 2024 | Dec 31, 2024 | -$15.38M | – |
| 2023 | Dec 29, 2023 | -$19.70M | – |
| 2022 | Dec 30, 2022 | -$101.63M | – |
| 2021 | Dec 31, 2021 | -$36.75M | -111.3% |
| 2020 | Dec 31, 2020 | $325.22M | +228.4% |
| 2019 | Dec 31, 2019 | $99.02M | -87.7% |
| 2018 | Dec 31, 2018 | $804.17M | – |
See a number that looks wrong?